期刊
ADVANCED SYNTHESIS & CATALYSIS
卷 355, 期 9, 页码 1780-1786出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/adsc.201201030
关键词
amine dehydrogenase; asymmetric catalysis; biocatalysis; chiral amines; directed evolution
资金
- GAANN fellowship by the US Dept. of Education
- NSF I/UCRC [0969003]
- NSF-MRI [0320786]
- Directorate For Engineering
- Div Of Industrial Innovation & Partnersh [0969003] Funding Source: National Science Foundation
- Div Of Biological Infrastructure
- Direct For Biological Sciences [0320786] Funding Source: National Science Foundation
The reductive amination of ketones to produce chiral amines is an important transformation in the production of pharmaceutical intermediates. Therefore, industrially applicable enzymatic methods that enable the selective synthesis of chiral amines could be very useful. Using a phenylalanine dehydrogenase scaffold devoid of amine dehydrogenase activity, a robust amine dehydrogenase has been evolved with a single two-site library allowing for the direct production of (R)-1-(4-fluorophenyl)-propyl-2-amine from para-fluorophenylacetone with a kcat value of 6.85s-1 and a KM value of 7.75mM for the ketone substrate. This is the first example of a highly active amine dehydrogenase capable of accepting aliphatic and benzylic ketone substrates. The stereoselectivity of the evolved amine dehydrogenase was very high (>99.8% ee) showing that high selectivity of the wild-type phenylalanine dehydrogenase was conserved in the evolution process. When paired with glucose/glucose dehydrogenase, NADH cofactor can be effficiently regenerated and the reaction driven to over 93% conversion. The broad specificity, high selectivity, and near complete conversion render this amine dehydrogenase an attractive target for further evolution toward pharmaceutical compounds and subsequent application.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据